A multicentre study of pembrolizumab time-of-day infusion patterns and clinical outcomes in non-small-cell lung cancer: too soon to promote morning infusions
Gespeichert in:
| Veröffentlicht in: | Annals of oncology 2022-11, Vol.33 (11), p.1202-1204 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1204 |
|---|---|
| container_issue | 11 |
| container_start_page | 1202 |
| container_title | Annals of oncology |
| container_volume | 33 |
| creator | Cortellini, A. Barrichello, A.P.C. Alessi, J.V. Ricciuti, B. Vaz, V.R. Newsom-Davis, T. Evans, J.S. Lamberti, G. Pecci, F. Viola, P. D’Alessio, A. Fulgenzi, C.A.M. Awad, M.M. Pinato, D.J. |
| description | |
| doi_str_mv | 10.1016/j.annonc.2022.07.1851 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2702194092</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0923753422037024</els_id><sourcerecordid>2702194092</sourcerecordid><originalsourceid>FETCH-LOGICAL-c412t-d2fa853c4ade6de1358de0f42652a5c4b0aba22e0b7c12e1c2d65faecf3a24663</originalsourceid><addsrcrecordid>eNqFkc2OFCEURonROD2tj6Bh6YYSqKKqy42ZTNQxmcSNrgkFF0OHnxYok_Zd5l2l0jNuXbE5934f9yD0htGOUTa-P3YqxhR1xynnHZ06dhDsGdoxMc7kQAf2HO3ozHsyiX64QtelHCml48znl-iqF7PoKRU79HCDw-qr0xBrBlzqas44WXyCsOTk3Z81qAVXF4AkS4w6YxftWlyK-KRqhRwLVtFg7V10Wnmc1qpTgNI43PqREpT3RIP32K_xJ9YqasgfcE0Jl9TW1IRPOYVUAYeUo2vMU0R5hV5Y5Qu8fnz36MfnT99v78j9ty9fb2_uiR4Yr8Rwqw6i14MyMBpgvTgYoHbgo-BK6GGhalGcA10mzTgwzc0orAJte8WHcez36N1lb2vya4VSZXBl66wipLVIPlHO5mG75x6JC6pzKiWDlafsgspnyajczMijvJiRmxlJJ7mZaXNvHyPWJYD5N_WkogEfLwC0j_52kGXRDtqxjMugqzTJ_SfiL83Dpk8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2702194092</pqid></control><display><type>article</type><title>A multicentre study of pembrolizumab time-of-day infusion patterns and clinical outcomes in non-small-cell lung cancer: too soon to promote morning infusions</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><source>EZB Electronic Journals Library</source><creator>Cortellini, A. ; Barrichello, A.P.C. ; Alessi, J.V. ; Ricciuti, B. ; Vaz, V.R. ; Newsom-Davis, T. ; Evans, J.S. ; Lamberti, G. ; Pecci, F. ; Viola, P. ; D’Alessio, A. ; Fulgenzi, C.A.M. ; Awad, M.M. ; Pinato, D.J.</creator><creatorcontrib>Cortellini, A. ; Barrichello, A.P.C. ; Alessi, J.V. ; Ricciuti, B. ; Vaz, V.R. ; Newsom-Davis, T. ; Evans, J.S. ; Lamberti, G. ; Pecci, F. ; Viola, P. ; D’Alessio, A. ; Fulgenzi, C.A.M. ; Awad, M.M. ; Pinato, D.J.</creatorcontrib><identifier>ISSN: 0923-7534</identifier><identifier>EISSN: 1569-8041</identifier><identifier>DOI: 10.1016/j.annonc.2022.07.1851</identifier><identifier>PMID: 35953005</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Antibodies, Monoclonal, Humanized - therapeutic use ; Antineoplastic Agents, Immunological - therapeutic use ; Carcinoma, Non-Small-Cell Lung - drug therapy ; Humans ; Lung Neoplasms - drug therapy</subject><ispartof>Annals of oncology, 2022-11, Vol.33 (11), p.1202-1204</ispartof><rights>2022 European Society for Medical Oncology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c412t-d2fa853c4ade6de1358de0f42652a5c4b0aba22e0b7c12e1c2d65faecf3a24663</citedby><cites>FETCH-LOGICAL-c412t-d2fa853c4ade6de1358de0f42652a5c4b0aba22e0b7c12e1c2d65faecf3a24663</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35953005$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cortellini, A.</creatorcontrib><creatorcontrib>Barrichello, A.P.C.</creatorcontrib><creatorcontrib>Alessi, J.V.</creatorcontrib><creatorcontrib>Ricciuti, B.</creatorcontrib><creatorcontrib>Vaz, V.R.</creatorcontrib><creatorcontrib>Newsom-Davis, T.</creatorcontrib><creatorcontrib>Evans, J.S.</creatorcontrib><creatorcontrib>Lamberti, G.</creatorcontrib><creatorcontrib>Pecci, F.</creatorcontrib><creatorcontrib>Viola, P.</creatorcontrib><creatorcontrib>D’Alessio, A.</creatorcontrib><creatorcontrib>Fulgenzi, C.A.M.</creatorcontrib><creatorcontrib>Awad, M.M.</creatorcontrib><creatorcontrib>Pinato, D.J.</creatorcontrib><title>A multicentre study of pembrolizumab time-of-day infusion patterns and clinical outcomes in non-small-cell lung cancer: too soon to promote morning infusions</title><title>Annals of oncology</title><addtitle>Ann Oncol</addtitle><subject>Antibodies, Monoclonal, Humanized - therapeutic use</subject><subject>Antineoplastic Agents, Immunological - therapeutic use</subject><subject>Carcinoma, Non-Small-Cell Lung - drug therapy</subject><subject>Humans</subject><subject>Lung Neoplasms - drug therapy</subject><issn>0923-7534</issn><issn>1569-8041</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkc2OFCEURonROD2tj6Bh6YYSqKKqy42ZTNQxmcSNrgkFF0OHnxYok_Zd5l2l0jNuXbE5934f9yD0htGOUTa-P3YqxhR1xynnHZ06dhDsGdoxMc7kQAf2HO3ozHsyiX64QtelHCml48znl-iqF7PoKRU79HCDw-qr0xBrBlzqas44WXyCsOTk3Z81qAVXF4AkS4w6YxftWlyK-KRqhRwLVtFg7V10Wnmc1qpTgNI43PqREpT3RIP32K_xJ9YqasgfcE0Jl9TW1IRPOYVUAYeUo2vMU0R5hV5Y5Qu8fnz36MfnT99v78j9ty9fb2_uiR4Yr8Rwqw6i14MyMBpgvTgYoHbgo-BK6GGhalGcA10mzTgwzc0orAJte8WHcez36N1lb2vya4VSZXBl66wipLVIPlHO5mG75x6JC6pzKiWDlafsgspnyajczMijvJiRmxlJJ7mZaXNvHyPWJYD5N_WkogEfLwC0j_52kGXRDtqxjMugqzTJ_SfiL83Dpk8</recordid><startdate>202211</startdate><enddate>202211</enddate><creator>Cortellini, A.</creator><creator>Barrichello, A.P.C.</creator><creator>Alessi, J.V.</creator><creator>Ricciuti, B.</creator><creator>Vaz, V.R.</creator><creator>Newsom-Davis, T.</creator><creator>Evans, J.S.</creator><creator>Lamberti, G.</creator><creator>Pecci, F.</creator><creator>Viola, P.</creator><creator>D’Alessio, A.</creator><creator>Fulgenzi, C.A.M.</creator><creator>Awad, M.M.</creator><creator>Pinato, D.J.</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202211</creationdate><title>A multicentre study of pembrolizumab time-of-day infusion patterns and clinical outcomes in non-small-cell lung cancer: too soon to promote morning infusions</title><author>Cortellini, A. ; Barrichello, A.P.C. ; Alessi, J.V. ; Ricciuti, B. ; Vaz, V.R. ; Newsom-Davis, T. ; Evans, J.S. ; Lamberti, G. ; Pecci, F. ; Viola, P. ; D’Alessio, A. ; Fulgenzi, C.A.M. ; Awad, M.M. ; Pinato, D.J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c412t-d2fa853c4ade6de1358de0f42652a5c4b0aba22e0b7c12e1c2d65faecf3a24663</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Antibodies, Monoclonal, Humanized - therapeutic use</topic><topic>Antineoplastic Agents, Immunological - therapeutic use</topic><topic>Carcinoma, Non-Small-Cell Lung - drug therapy</topic><topic>Humans</topic><topic>Lung Neoplasms - drug therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cortellini, A.</creatorcontrib><creatorcontrib>Barrichello, A.P.C.</creatorcontrib><creatorcontrib>Alessi, J.V.</creatorcontrib><creatorcontrib>Ricciuti, B.</creatorcontrib><creatorcontrib>Vaz, V.R.</creatorcontrib><creatorcontrib>Newsom-Davis, T.</creatorcontrib><creatorcontrib>Evans, J.S.</creatorcontrib><creatorcontrib>Lamberti, G.</creatorcontrib><creatorcontrib>Pecci, F.</creatorcontrib><creatorcontrib>Viola, P.</creatorcontrib><creatorcontrib>D’Alessio, A.</creatorcontrib><creatorcontrib>Fulgenzi, C.A.M.</creatorcontrib><creatorcontrib>Awad, M.M.</creatorcontrib><creatorcontrib>Pinato, D.J.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Annals of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cortellini, A.</au><au>Barrichello, A.P.C.</au><au>Alessi, J.V.</au><au>Ricciuti, B.</au><au>Vaz, V.R.</au><au>Newsom-Davis, T.</au><au>Evans, J.S.</au><au>Lamberti, G.</au><au>Pecci, F.</au><au>Viola, P.</au><au>D’Alessio, A.</au><au>Fulgenzi, C.A.M.</au><au>Awad, M.M.</au><au>Pinato, D.J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A multicentre study of pembrolizumab time-of-day infusion patterns and clinical outcomes in non-small-cell lung cancer: too soon to promote morning infusions</atitle><jtitle>Annals of oncology</jtitle><addtitle>Ann Oncol</addtitle><date>2022-11</date><risdate>2022</risdate><volume>33</volume><issue>11</issue><spage>1202</spage><epage>1204</epage><pages>1202-1204</pages><issn>0923-7534</issn><eissn>1569-8041</eissn><cop>England</cop><pub>Elsevier Ltd</pub><pmid>35953005</pmid><doi>10.1016/j.annonc.2022.07.1851</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0923-7534 |
| ispartof | Annals of oncology, 2022-11, Vol.33 (11), p.1202-1204 |
| issn | 0923-7534 1569-8041 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2702194092 |
| source | MEDLINE; Alma/SFX Local Collection; EZB Electronic Journals Library |
| subjects | Antibodies, Monoclonal, Humanized - therapeutic use Antineoplastic Agents, Immunological - therapeutic use Carcinoma, Non-Small-Cell Lung - drug therapy Humans Lung Neoplasms - drug therapy |
| title | A multicentre study of pembrolizumab time-of-day infusion patterns and clinical outcomes in non-small-cell lung cancer: too soon to promote morning infusions |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T19%3A12%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20multicentre%20study%20of%20pembrolizumab%20time-of-day%20infusion%20patterns%20and%20clinical%20outcomes%20in%20non-small-cell%20lung%20cancer:%20too%20soon%20to%20promote%20morning%20infusions&rft.jtitle=Annals%20of%20oncology&rft.au=Cortellini,%20A.&rft.date=2022-11&rft.volume=33&rft.issue=11&rft.spage=1202&rft.epage=1204&rft.pages=1202-1204&rft.issn=0923-7534&rft.eissn=1569-8041&rft_id=info:doi/10.1016/j.annonc.2022.07.1851&rft_dat=%3Cproquest_cross%3E2702194092%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2702194092&rft_id=info:pmid/35953005&rft_els_id=S0923753422037024&rfr_iscdi=true |